Human pituitary tumor-transforming gene induces angiogenesis

被引:121
作者
Ishikawa, H [1 ]
Heaney, AP [1 ]
Yu, R [1 ]
Horwitz, GA [1 ]
Melmed, S [1 ]
机构
[1] Univ Calif Los Angeles, Cedars Sinai Res Inst, Sch Med, Los Angeles, CA 90048 USA
关键词
D O I
10.1210/jc.86.2.867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiogenesis is a key determinant and rate-limiting step in tumor progression and metastatic spread, As pituitary tumor-transforming gene (PTTG) induces basic fibroblast growth factor (bFGF), we tested angiogenesis induced by conditioned medium (CM) derived from NIH-3T3 transfectants overexpressing wild-type human PTTG (WT-hPTTG-CM). We also examined the relationship between PTTG expression and tumor vascularity in a series of human tumors. CM from Wt-hPTTG transfectants induced proliferation, migration, and tube formation of human umbilical vein endothelial, cells in vitro. The bFGF concentration in WT-hPTTG-CM was elevated (10.5 +/- 0.56) compared with CM from nontransfected NIH-3T3 cells (3.3 +/- 0.56 pg/mL), and addition of anti-bFGF antibody to CM abrogated these angiogenesis markers (P < 0.01). In vivo, concentrated WT-hPTTG-CM induced chick chorioallantoic membrane spoke-wheel-like appearances. Moreover, CM derived from hPTTG transfectants harboring a point mutation on the C-terminus proline-rich region of PTTG induced weaker angiogenic activity than WT-hPTTG-CM (P < 0.01). Thus, human PTTG induces an angiogenic phenotype in both in vitro and in vivo angiogenesis models, and high PTTG messenger ribonucleic acid is associated with an angiogenic phenotype in human tumors. These PTTG-directed angiogenic actions may be mediated through bFGF, which also contributes to tumor growth.
引用
收藏
页码:867 / 874
页数:8
相关论文
共 31 条
  • [1] ASSAYS FOR ANGIOGENESIS - A REVIEW
    AUERBACH, R
    AUERBACH, W
    POLAKOWSKI, I
    [J]. PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) : 1 - 11
  • [2] Brooks PC, 1999, METH MOL B, V129, P257
  • [3] Blood vessel maturation: Vascular development comes of age
    Darland, DC
    D'Amore, PA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 157 - 158
  • [4] PROCESSING, SECRETION, AND BIOLOGICAL PROPERTIES OF A NOVEL GROWTH-FACTOR OF THE FIBROBLAST GROWTH-FACTOR FAMILY WITH ONCOGENIC POTENTIAL
    DELLIBOVI, P
    CURATOLA, AM
    NEWMAN, KM
    SATO, Y
    MOSCATELLI, D
    HEWICK, RM
    RIFKIN, DB
    BASILICO, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (07) : 2933 - 2941
  • [5] ANGIOGENESIS, NEOVASCULAR PROLIFERATION AND VASCULAR PATHOPHYSIOLOGY AS TARGETS FOR CANCER-THERAPY
    DENEKAMP, J
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1993, 66 (783) : 181 - 196
  • [6] DIRECT ARTERIAL VASCULARIZATION OF ESTROGEN-INDUCED PROLACTIN-SECRETING ANTERIOR-PITUITARY TUMORS
    ELIAS, KA
    WEINER, RI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14): : 4549 - 4553
  • [7] FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
  • [8] MOLECULAR MECHANISMS OF ANGIOGENESIS - FIBROBLAST GROWTH-FACTOR SIGNAL-TRANSDUCTION
    FRIESEL, RE
    MACIAG, T
    [J]. FASEB JOURNAL, 1995, 9 (10) : 919 - 925
  • [9] Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis
    Heaney, AP
    Horwitz, GA
    Wang, ZY
    Singson, R
    Melmed, S
    [J]. NATURE MEDICINE, 1999, 5 (11) : 1317 - 1321
  • [10] Expression of pituitary-tumour transforming gene in colorectal tumours
    Heaney, AP
    Singson, R
    McCabe, CJ
    Nelson, V
    Nakashima, M
    Melmed, S
    [J]. LANCET, 2000, 355 (9205) : 716 - 719